The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target
about
sameAs
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urineMSMB variation and prostate cancer risk: clues towards a possible fungal etiologyRNA-Seq quantification of the human small airway epithelium transcriptomeProteomic analysis of whole human saliva detects enhanced expression of interleukin-1 receptor antagonist, thioredoxin and lipocalin-1 in cigarette smokers compared to non-smokers.Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostatePSP94, an upstream signaling mediator of prostasin found highly elevated in ovarian cancer.A basal stem cell signature identifies aggressive prostate cancer phenotypes.Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populationsIdentification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine.MSMB gene variant alters the association between prostate cancer and number of sexual partners.The genomic landscape of prostate cancerGrowth inhibition properties of the putative prostate cancer biomarkers PSP94 and CRISP-3Promoter Polymorphism (rs12770170, -184C/T) of Microseminoprotein, Beta as a Risk Factor for Benign Prostatic Hyperplasia in Korean Population.
P2860
Q21562160-799028EB-DB19-4013-8145-AB6DED4A4B71Q27025389-80388E7D-DC19-4E59-8B20-CAAB46F696BCQ34178271-E7E45441-EE35-4809-A707-6003C11E258BQ34396094-2E067FDB-B642-4E3B-8387-FF5534710B1CQ35838295-996EE7DF-2863-497F-ADD9-C673DAC4130FQ35966261-F8A80590-E558-4869-99B2-F5904228AA61Q36332070-D01E8171-20CA-4B87-A2A0-5125C290BA97Q36590875-89BA57F3-376D-415A-8A17-8F1A7C3B4D98Q36811800-3522F462-A78C-46BE-BADC-BDB57D236217Q37712250-AA36148C-262E-4055-A7F1-185F6247A141Q38109474-26B6F931-78A3-41CB-97A9-3A6E705ED259Q39628496-84CA5045-C2C4-46D5-BB1D-FD380ED8BF80Q41539781-A9DE45F8-11B6-4033-A56E-604C1A128118
P2860
The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The potential value of microse ...... omarker and therapeutic target
@ast
The potential value of microse ...... omarker and therapeutic target
@en
The potential value of microse ...... omarker and therapeutic target
@nl
type
label
The potential value of microse ...... omarker and therapeutic target
@ast
The potential value of microse ...... omarker and therapeutic target
@en
The potential value of microse ...... omarker and therapeutic target
@nl
altLabel
The potential value of microse ...... omarker and therapeutic target
@en
prefLabel
The potential value of microse ...... omarker and therapeutic target
@ast
The potential value of microse ...... omarker and therapeutic target
@en
The potential value of microse ...... omarker and therapeutic target
@nl
P2093
P2860
P50
P356
P1433
P1476
The potential value of microse ...... omarker and therapeutic target
@en
The potential value of microse ...... omarker and therapeutic target
@en
P2093
Anne Y Warren
Anne Y. Warren
Hayley C Whitaker
Hayley C. Whitaker
P2860
P356
10.1002/PROS.21059
P407
P577
2009-01-01T00:00:00Z
2010-02-15T00:00:00Z